Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons S.S. (Shiral) Gangadin

Publicaties

Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects:: A comparison with prescription dose

Beyond the Need for Speed:: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode Psychosis

Citalopram serum concentrations in men and women of pre- and post-menopausal age

Correction: Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients

Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial

External validation and recalibration of the Psychosis Metabolic Risk Calculator (PsyMetRiC) in young adults with chronic psychotic disorders in The Netherlands

Negative association between cognitive functioning and antipsychotic D2 receptor occupancy, affinity, and dose after first episode psychosis

The Association Between Attachment Style and Symptomatic, Social, and Personal Recovery: A Comparison Between Male and Female Patients Remitted From Their First-Episode Psychosis

The direct and indirect effects of antipsychotic drugs on negative symptoms

The Impact of Sex and Age on Antipsychotic Serum Concentrations

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 5 – GendergelijkheidSDG 16 – Vrede, rechtvaardigheid en sterke instellingen

Meer informatie over de Sustainable Development Goals.